Approaches to Imaging Immune Activation Using PET.
Where this comes from
- Record sourced from PubMed, PMID 40306967.
- Also identified by DOI 10.2967/jnumed.124.268289 and PMC identifier 12175994.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This review explores the role of PET in imaging immune activation, particularly in oncology. <sup>18</sup>F-FDG is widely used for assessing treatment response to immunotherapies and can demonstrate unique response patterns as well as immune-related adverse events. However, because of the limited specificity of <sup>18</sup>F-FDG, newer PET radiopharmaceuticals targeting specific cellular or subcellular components of the immune system have been developed that can provide more precise information. The development of immune-specific PET radiopharmaceuticals offers significant potential for improving immune monitoring in both clinical practice and research.
Medical subject headings
- Positron-Emission Tomography